{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:41:55Z","timestamp":1791830515127,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81041071"],"award-info":[{"award-number":["81041071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30901985"],"award-info":[{"award-number":["30901985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Great Program of Science Foundation of Tianjin","award":["12JCZDJC26300"],"award-info":[{"award-number":["12JCZDJC26300"]}]},{"name":"Great Program of Science Foundation of Tianjin","award":["10JCZDJC21100"],"award-info":[{"award-number":["10JCZDJC21100"]}]},{"name":"Program for Science and Technology in Medical College of Chinese People\u2019s Armed Police Forces","award":["WHZ201202"],"award-info":[{"award-number":["WHZ201202"]}]},{"name":"Program for Science and Technology in Medical College of Chinese People\u2019s Armed Police Forces","award":["WYM201105"],"award-info":[{"award-number":["WYM201105"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.cyto.2012.04.013","type":"journal-article","created":{"date-parts":[[2012,5,9]],"date-time":"2012-05-09T12:04:58Z","timestamp":1336565098000},"page":"145-155","source":"Crossref","is-referenced-by-count":101,"title":["Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion"],"prefix":"10.1016","volume":"59","author":[{"given":"Yue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Long","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.04.013_b0005","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cyto.2012.04.013_b0010","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/107999099313866","article-title":"Regulation of interleukin-8 gene expression","volume":"19","author":"Roebuck","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0020","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 Pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","article-title":"Interleukin-8 and human cancer biology","volume":"12","author":"Xie","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2012.04.013_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1349-7006.2005.00059.x","article-title":"Chemokines in tumor progression and metastasis","volume":"96","author":"Tanaka","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cyto.2012.04.013_b0035","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/gyno.1998.5198","article-title":"The chemotactic cytokine interleukin-8 \u2013 a cyst fluid marker for malignant epithelial ovarian cancer?","volume":"71","author":"Ivarsson","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cyto.2012.04.013_b0040","first-page":"777","article-title":"Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas","volume":"79","author":"Ivarsson","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.cyto.2012.04.013_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1525-1438.2000.00003.x","article-title":"Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel","volume":"10","author":"Penson","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0015-0282(01)01804-0","article-title":"Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology","volume":"75","author":"Fasciani","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cyto.2012.04.013_b0055","first-page":"5","article-title":"Expression of metastasis-related genes in human epithelial ovarian tumors","volume":"20","author":"Herrera","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cyto.2012.04.013_b0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.clinbiochem.2004.01.014","article-title":"Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients","volume":"37","author":"Kassim","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cyto.2012.04.013_b0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","article-title":"Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer","volume":"102","author":"Lokshin","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cyto.2012.04.013_b0070","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"2nd","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0075","first-page":"375","article-title":"Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors","volume":"31","author":"Nowak","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.cyto.2012.04.013_b0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/djn024","article-title":"Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth","volume":"100","author":"Merritt","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cyto.2012.04.013_b0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/ijgc-00009577-200503000-00009","article-title":"Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens","volume":"15","author":"Uslu","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cyto.2011.06.005","article-title":"Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells","volume":"56","author":"Wang","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.04.013_b0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/1541-7786.MCR-08-0093","article-title":"Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer","volume":"6","author":"Li","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2010.02.019","article-title":"Autocrine production of Interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells","volume":"295","author":"Wang","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cyto.2012.04.013_b0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/abio.1994.1186","article-title":"Quantitative zymography: detection of picogram quantities of gelatinases","volume":"218","author":"Kleiner","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cyto.2012.04.013_b0110","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4161\/cbt.6.6.4093","article-title":"Reciprocal regulation of 5alpha-dihydrotestosterone, interleukin-6 and interleukin-8 during proliferation of epithelial ovarian carcinoma","volume":"6","author":"Wang","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cyto.2012.04.013_b0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cyto.2009.03.013","article-title":"Reciprocal regulation of 17beta-estradiol, interleukin-6 and interleukin-8 during growth and progression of epithelial ovarian cancer","volume":"46","author":"Yang","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.04.013_b0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10555-007-9068-9","article-title":"Chemokines in tumor angiogenesis and metastasis","volume":"26","author":"Singh","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cyto.2012.04.013_b0125","first-page":"2104","article-title":"Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer","volume":"6","author":"Inoue","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.neo.7900124","article-title":"Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice","volume":"3","author":"Kim","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.cyto.2012.04.013_b0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3727\/096504001108747567","article-title":"Interleukin 8: an autocrine growth factor for human ovarian cancer","volume":"12","author":"Xu","year":"2000","journal-title":"Oncol Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0140","first-page":"5334","article-title":"Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8","volume":"60","author":"Huang","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/1097-0215(20001115)88:4<566::AID-IJC8>3.0.CO;2-D","article-title":"Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells","volume":"88","author":"Alper","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0150","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1006\/cyto.1998.0465","article-title":"Cxc chemokine receptor expression on human endothelial cells","volume":"11","author":"Murdoch","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.04.013_b0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00006676-200007000-00051","article-title":"Autocrine growth effect of IL-8 and GRO on a human pancreatic cancer cell line, Capan-1","volume":"21","author":"Takamori","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.cyto.2012.04.013_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.1999.0518","article-title":"Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro","volume":"12","author":"Brew","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2012.04.013_b0165","first-page":"627","article-title":"Induction of interleukin-8 (CXCL-8) by tumor necrosis facto and leukemia inhibitory factor in pancreatic carcinoma cells: Impact of CXCL-8 as an autocrine growth factor","volume":"31","author":"Kamohara","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cyto.2012.04.013_b0170","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.10424","article-title":"Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop","volume":"99","author":"Lang","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0175","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/ijc.22930","article-title":"Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells","volume":"121","author":"Yao","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0180","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1158\/0008-5472.CAN-07-1162","article-title":"Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer","volume":"67","author":"Araki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-4598-8-57","article-title":"Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs","volume":"8","author":"Singh","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0190","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/sj.onc.1210536","article-title":"HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells","volume":"26","author":"Maxwell","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2012.04.013_b0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0002-9440(10)64164-8","article-title":"Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma","volume":"161","author":"Huang","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2012.04.013_b0200","first-page":"3711","article-title":"Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic","volume":"5","author":"Shi","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0205","first-page":"2290","article-title":"Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer","volume":"60","author":"Inoue","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0210","first-page":"2786","article-title":"Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8","volume":"9","author":"Karashima","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0215","first-page":"3167","article-title":"Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB","volume":"9","author":"Mian","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0220","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4049\/jimmunol.164.5.2769","article-title":"IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration","volume":"164","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.04.013_b0225","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1541-7786.MCR-07-0032","article-title":"Interleukin-8 signaling promotes translational of regulation cyclin D in androgen-independent prostate cancer cells","volume":"5","author":"MacManus","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cyto.2012.04.013_b0230","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.1074\/jbc.C800207200","article-title":"CXCL8\/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3\/Bcl10\/Malt1) complex","volume":"284","author":"Martin","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.04.013_b0235","first-page":"955","article-title":"Adenoviral-mediated gene therapy of human bladder cancer with antisense interleukine-8","volume":"8","author":"Inou","year":"2001","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cyto.2012.04.013_b0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2004.06.046","article-title":"Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity","volume":"95","author":"Bar","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cyto.2012.04.013_b0245","first-page":"1105","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2012.04.013_b0250","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.04.013_b0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156800908783497159","article-title":"Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery","volume":"8","author":"Cheng","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.cyto.2012.04.013_b0260","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1074\/jbc.275.10.6868","article-title":"Chemokine receptors CXCR-1\/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells","volume":"275","author":"Venkatakrishnan","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.04.013_b0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2006.11.014","article-title":"Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation","volume":"56","author":"Luppi","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cyto.2012.04.013_b0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/pupt.2001.0323","article-title":"The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-a-mediated inhibition of spontaneous neutrophil apoptosis","volume":"15","author":"Glynn","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.cyto.2012.04.013_b0275","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.cellsig.2006.05.019","article-title":"Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway","volume":"18","author":"Meng","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.cyto.2012.04.013_b0280","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1210\/me.2004-0082","article-title":"Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1\/2 on cancer cell proliferation","volume":"18","author":"Steinmetz","year":"2004","journal-title":"Mol Endocrinol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:40:33Z","timestamp":1572745233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1043466612001433"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.04.013","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}